Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 168,024 | 28,507 | -237,892 | -291,754 | -287,100 |
| Depreciation Amortization | 3,924 | 5,276 | 3,791 | 3,699 | 3,454 |
| Accounts receivable | 93,557 | 149,350 | -150,683 | 13,052 | 34,062 |
| Accounts payable and accrued liabilities | -19,556 | -3,938 | 23,760 | -4,548 | 874 |
| Other Working Capital | -5,842 | 55,894 | -34,350 | -76,754 | 44,567 |
| Other Operating Activity | -378,620 | -255,529 | 220,490 | 115,181 | 166,711 |
| Operating Cash Flow | $-138,513 | $-20,440 | $-174,884 | $-241,124 | $-37,432 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -1,289 |
| Net Acquisitions | N/A | N/A | 6,997 | N/A | N/A |
| Purchase Of Investment | -103,838 | 0 | -19,507 | -127,382 | -182,485 |
| Sale Of Investment | 21,462 | 14,888 | 157,642 | 0 | 181,364 |
| Other Investing Activity | 457,463 | 215,433 | -492 | -39,468 | -136,000 |
| Investing Cash Flow | $375,087 | $230,321 | $144,640 | $-166,850 | $-138,410 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 36,979 | N/A | 240,679 | N/A |
| Debt Repayment | -233,185 | -260,387 | 0 | -190,750 | N/A |
| Common Stock Issued | 7,894 | 1,455 | 72,412 | 7,049 | 54,304 |
| Common Stock Repurchased | 353 | 926 | 1,809 | 2,320 | N/A |
| Other Financing Activity | -48,767 | 34,053 | -4,621 | -4,972 | -2,425 |
| Financing Cash Flow | $-273,705 | $-186,974 | $69,600 | $54,326 | $51,879 |
| Beginning Cash Position | 126,250 | 103,343 | 63,987 | 417,635 | 541,598 |
| End Cash Position | 89,119 | 126,250 | 103,343 | 63,987 | 417,635 |
| Net Cash Flow | $-37,131 | $22,907 | $39,356 | $-353,648 | $-123,963 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138,513 | -20,440 | -174,884 | -241,124 | -37,432 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -1,289 |
| Free Cash Flow | -138,513 | -20,440 | -174,884 | -241,124 | -38,721 |